Guangdong Kaiyang Medical Technology Group Co. Ltd., commonly referred to as Kaiyang Medical, is a leading player in the medical technology industry, headquartered in Guangdong, China. Established in 2003, the company has rapidly expanded its operations across various regions, focusing on innovative healthcare solutions. Specialising in the development and manufacturing of advanced medical devices, Kaiyang Medical offers a diverse range of products, including diagnostic equipment and surgical instruments. Their commitment to quality and innovation sets them apart in a competitive market, ensuring they meet the evolving needs of healthcare professionals. With a strong market presence, Kaiyang Medical has achieved significant milestones, positioning itself as a trusted name in the medical technology sector. Their dedication to research and development continues to drive their success, making them a key contributor to advancements in healthcare technology.
How does Guangdong Kaiyang Medical Technology Group Co. Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Guangdong Kaiyang Medical Technology Group Co. Ltd's score of 20 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Guangdong Kaiyang Medical Technology Group Co. Ltd, headquartered in China, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to address carbon emissions at this time. As there are no emissions data or reduction initiatives available, it is unclear how Guangdong Kaiyang Medical Technology Group aligns with industry standards for climate action. The absence of emissions reporting may reflect a broader trend within the medical technology sector, where companies are increasingly being urged to disclose their environmental impact and set ambitious targets for emissions reduction. In summary, without available emissions data or climate commitments, Guangdong Kaiyang Medical Technology Group's current stance on carbon emissions and climate action remains undefined.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Guangdong Kaiyang Medical Technology Group Co. Ltd has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
